Growing community of inventors

Shanghai, China

Jinlin Guo

Average Co-Inventor Count = 5.97

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Jinlin GuoChenghai Zhang (4 patents)Jinlin GuoLingqiao Zhu (3 patents)Jinlin GuoWei Dang (3 patents)Jinlin GuoJie Zhao (2 patents)Jinlin GuoHonghai Gao (2 patents)Jinlin GuoYujing Yuan (2 patents)Jinlin GuoYan Yang (1 patent)Jinlin GuoLe Zhao (1 patent)Jinlin GuoYang Wang (1 patent)Jinlin GuoHaomin Huang (1 patent)Jinlin GuoZhenping Zhu (1 patent)Jinlin GuoJianhe Chen (1 patent)Jinlin GuoLin Ma (1 patent)Jinlin GuoYipan Wu (1 patent)Jinlin GuoQiuling Zou (1 patent)Jinlin GuoShun Hu (1 patent)Jinlin GuoJinlin Guo (4 patents)Chenghai ZhangChenghai Zhang (4 patents)Lingqiao ZhuLingqiao Zhu (3 patents)Wei DangWei Dang (3 patents)Jie ZhaoJie Zhao (34 patents)Honghai GaoHonghai Gao (3 patents)Yujing YuanYujing Yuan (2 patents)Yan YangYan Yang (12 patents)Le ZhaoLe Zhao (9 patents)Yang WangYang Wang (7 patents)Haomin HuangHaomin Huang (7 patents)Zhenping ZhuZhenping Zhu (7 patents)Jianhe ChenJianhe Chen (2 patents)Lin MaLin Ma (2 patents)Yipan WuYipan Wu (1 patent)Qiuling ZouQiuling Zou (1 patent)Shun HuShun Hu (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Shanghai Mabgeek Biotech. Co., Ltd (2 from 2 patents)

2. Sunshine Guojian Pharmaceutical (shanghai) Co., Ltd. (1 from 8 patents)

3. Sunshine Guojian Pharmaceutical (shanghai) Co., Lt (1 from 1 patent)


4 patents:

1. 12180303 - Anti-human MASP-2 antibody, preparation method therefor and application thereof

2. 11939387 - Anti-human interleukin-4 receptor alpha antibody and preparation method and application thereof

3. 11254746 - Anti-PD-1 monoclonal antibody, and preparation method therefor and application thereof

4. 10738112 - Anti-human interleukin-17A monoclonal antibody

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…